2017-03-28 |
2017-03-28 |
A
Achat
|
Byrnes Michael
CFO and Treasurer
|
3 000
+30.0%
1,28
3 854 USD
|
3 000
+30.0%
|
1,28
|
3 854 USD
|
|
2016-12-08 |
2016-12-07 |
A
Achat
|
Grais Linda S
President and CEO
Administrateur exécutif
|
7 000
+11.1%
2,14
14 980 USD
|
7 000
+11.1%
|
2,14
|
14 980 USD
|
|
2016-10-17 |
2016-10-13 |
A
Achat
|
Bukofzer Stan
Chief Medical Officer
Dirigeant
|
2 500
+inf%
2,64
6 598 USD
|
2 500
+inf%
|
2,64
|
6 598 USD
|
|
2016-12-30 |
2016-09-12 |
V
Vente
|
POWELL MICHAEL
Administrateur non-exécutif
|
74
-0.8%
2,29
170 USD
|
74
-0.8%
|
2,29
|
170 USD
|
|
2016-12-30 |
2016-09-12 |
V
Vente
|
POWELL MICHAEL
Administrateur non-exécutif
|
1 066
-0.8%
2,29
2 443 USD
|
1 066
-0.8%
|
2,29
|
2 443 USD
|
|
2016-12-30 |
2016-09-12 |
V
Vente
|
POWELL MICHAEL
Administrateur non-exécutif
|
5 372
-0.8%
2,29
12 313 USD
|
5 372
-0.8%
|
2,29
|
12 313 USD
|
|
2016-03-07 |
2016-03-04 |
A
Achat
|
Grais Linda S
President and CEO
Administrateur exécutif
|
3 000
+5.0%
3,19
9 570 USD
|
3 000
+5.0%
|
3,19
|
9 570 USD
|
|
2016-01-25 |
2016-01-22 |
A
Achat
|
Grais Linda S
President and CEO
Administrateur exécutif
|
10 000
+20.0%
2,38
23 800 USD
|
10 000
+20.0%
|
2,38
|
23 800 USD
|
|
2016-01-19 |
2016-01-15 |
A
Achat
|
Grais Linda S
President and CEO
Administrateur exécutif
|
10 000
+25.0%
2,08
20 800 USD
|
10 000
+25.0%
|
2,08
|
20 800 USD
|
|
2016-01-19 |
2016-01-15 |
A
Achat
|
Aggarwal Gaurav
Chief Business Officer
Dirigeant
|
10 000
+100.0%
2,15
21 500 USD
|
10 000
+100.0%
|
2,15
|
21 500 USD
|
|
2016-01-19 |
2016-01-15 |
A
Achat
|
Byrnes Michael
CFO and Treasurer
Dirigeant
|
3 500
+53.8%
2,07
7 245 USD
|
3 500
+53.8%
|
2,07
|
7 245 USD
|
|
2015-06-24 |
2015-06-23 |
A
Achat
|
WIERENGA WENDALL
Administrateur non-exécutif
|
5 000
+inf%
3,71
18 550 USD
|
5 000
+inf%
|
3,71
|
18 550 USD
|
|
2015-05-07 |
2015-05-07 |
A
Achat
|
Patni Rajiv
Chief Development Officer
Dirigeant
|
5 050
+inf%
3,97
20 049 USD
|
5 050
+inf%
|
3,97
|
20 049 USD
|
|
2015-05-06 |
2015-05-06 |
A
Achat
|
Aggarwal Gaurav
Chief Business Officer
Dirigeant
|
7 500
+300.0%
3,62
27 150 USD
|
7 500
+300.0%
|
3,62
|
27 150 USD
|
|
2015-05-06 |
2015-05-06 |
A
Achat
|
Byrnes Michael
CFO and Treasurer
Dirigeant
|
2 500
+62.5%
3,61
9 025 USD
|
2 500
+62.5%
|
3,61
|
9 025 USD
|
|
2015-05-06 |
2015-05-06 |
A
Achat
|
Grais Linda S
President and CEO
Administrateur exécutif
|
30 000
+300.0%
3,73
111 900 USD
|
30 000
+300.0%
|
3,73
|
111 900 USD
|
|
2014-10-02 |
2014-10-01 |
A
Achat
|
Byrnes Michael
VP, Finance & Treasurer
Dirigeant
|
2 000
+100.0%
4,81
9 620 USD
|
2 000
+100.0%
|
4,81
|
9 620 USD
|
|
2014-07-15 |
2014-07-11 |
A
Achat
|
TETLOW SHARON
Acting CFO & Treasurer
Dirigeant
|
3 000
+inf%
5,83
17 487 USD
|
3 000
+inf%
|
5,83
|
17 487 USD
|
|
2014-07-15 |
2014-07-11 |
A
Achat
|
Grais Linda S
President and CEO
Administrateur exécutif
|
10 000
+inf%
5,93
59 280 USD
|
10 000
+inf%
|
5,93
|
59 280 USD
|
|
2013-07-17 |
2013-07-15 |
A
Achat
|
Kjellson Nina S
Administrateur non-exécutif
|
431 435
+109.4%
6,03
2 600 000 USD
|
431 435
+109.4%
|
6,03
|
2 600 000 USD
|
|
2013-07-17 |
2013-07-15 |
A
Achat
|
SOFINNOVA VENTURE PARTNERS VI L P
Actionnaire important
|
4 400
+45.9%
6,03
26 516 USD
|
4 400
+45.9%
|
6,03
|
26 516 USD
|
|
2013-07-17 |
2013-07-15 |
A
Achat
|
SOFINNOVA VENTURE PARTNERS VI L P
Actionnaire important
|
63 957
+45.9%
6,03
385 430 USD
|
63 957
+45.9%
|
6,03
|
385 430 USD
|
|
2013-07-17 |
2013-07-15 |
A
Achat
|
POWELL MICHAEL
Administrateur non-exécutif
|
4 400
+45.9%
6,03
26 516 USD
|
4 400
+45.9%
|
6,03
|
26 516 USD
|
|
2013-07-17 |
2013-07-15 |
A
Achat
|
POWELL MICHAEL
Administrateur non-exécutif
|
63 957
+45.9%
6,03
385 430 USD
|
63 957
+45.9%
|
6,03
|
385 430 USD
|
|
2013-07-17 |
2013-07-15 |
A
Achat
|
POWELL MICHAEL
Administrateur non-exécutif
|
322 809
+45.9%
6,03
1 945 376 USD
|
322 809
+45.9%
|
6,03
|
1 945 376 USD
|
|
2013-07-17 |
2013-07-15 |
A
Achat
|
SOFINNOVA VENTURE PARTNERS VI L P
Actionnaire important
|
322 809
+45.9%
6,03
1 945 376 USD
|
322 809
+45.9%
|
6,03
|
1 945 376 USD
|
|
2013-07-16 |
2013-07-15 |
A
Achat
|
BLAIR JAMES C
Actionnaire important
|
331 873
+21.2%
6,03
1 999 999 USD
|
331 873
+21.2%
|
6,03
|
1 999 999 USD
|
|
2013-07-16 |
2013-07-15 |
A
Achat
|
BLAIR JAMES C
Actionnaire important
|
7 333
+inf%
6,03
44 192 USD
|
7 333
+inf%
|
6,03
|
44 192 USD
|
|
2013-07-16 |
2013-07-15 |
A
Achat
|
SCHOEMAKER KATHLEEN K
Actionnaire important
|
331 873
+21.2%
6,03
1 999 999 USD
|
331 873
+21.2%
|
6,03
|
1 999 999 USD
|
|
2013-07-16 |
2013-07-15 |
A
Achat
|
SCHOEMAKER KATHLEEN K
Actionnaire important
|
7 333
+inf%
6,03
44 192 USD
|
7 333
+inf%
|
6,03
|
44 192 USD
|
|
2013-07-16 |
2013-07-15 |
A
Achat
|
Halak Brian K
Actionnaire important
|
331 873
+21.2%
6,03
1 999 999 USD
|
331 873
+21.2%
|
6,03
|
1 999 999 USD
|
|
2013-07-16 |
2013-07-15 |
A
Achat
|
Halak Brian K
Actionnaire important
|
7 333
+inf%
6,03
44 192 USD
|
7 333
+inf%
|
6,03
|
44 192 USD
|
|
2013-07-16 |
2013-07-15 |
A
Achat
|
TREU JESSE I
Actionnaire important
|
331 873
+21.2%
6,03
1 999 999 USD
|
331 873
+21.2%
|
6,03
|
1 999 999 USD
|
|
2013-07-16 |
2013-07-15 |
A
Achat
|
TREU JESSE I
Actionnaire important
|
7 333
+inf%
6,03
44 192 USD
|
7 333
+inf%
|
6,03
|
44 192 USD
|
|
2013-07-16 |
2013-07-15 |
A
Achat
|
VITULLO NICOLE
Actionnaire important
|
331 873
+21.2%
6,03
1 999 999 USD
|
331 873
+21.2%
|
6,03
|
1 999 999 USD
|
|
2013-07-16 |
2013-07-15 |
A
Achat
|
VITULLO NICOLE
Actionnaire important
|
7 333
+inf%
6,03
44 192 USD
|
7 333
+inf%
|
6,03
|
44 192 USD
|
|
2013-07-16 |
2013-07-15 |
A
Achat
|
DOVEY BRIAN H
Actionnaire important
|
331 873
+21.2%
6,03
1 999 999 USD
|
331 873
+21.2%
|
6,03
|
1 999 999 USD
|
|
2013-07-16 |
2013-07-15 |
A
Achat
|
DOVEY BRIAN H
Actionnaire important
|
7 333
+inf%
6,03
44 192 USD
|
7 333
+inf%
|
6,03
|
44 192 USD
|
|
2013-07-16 |
2013-07-15 |
A
Achat
|
Domain Partners VI, L.P.
Actionnaire important
|
331 873
+21.2%
6,03
1 999 999 USD
|
331 873
+21.2%
|
6,03
|
1 999 999 USD
|
|
2013-07-16 |
2013-07-15 |
A
Achat
|
BLAIR JAMES C
Actionnaire important
|
988 285
+inf%
6,03
5 955 801 USD
|
988 285
+inf%
|
6,03
|
5 955 801 USD
|
|
2013-07-16 |
2013-07-15 |
A
Achat
|
SCHOEMAKER KATHLEEN K
Actionnaire important
|
988 285
+inf%
6,03
5 955 801 USD
|
988 285
+inf%
|
6,03
|
5 955 801 USD
|
|
2013-07-16 |
2013-07-15 |
A
Achat
|
Halak Brian K
Actionnaire important
|
988 285
+inf%
6,03
5 955 801 USD
|
988 285
+inf%
|
6,03
|
5 955 801 USD
|
|
2013-07-16 |
2013-07-15 |
A
Achat
|
TREU JESSE I
Actionnaire important
|
988 285
+inf%
6,03
5 955 801 USD
|
988 285
+inf%
|
6,03
|
5 955 801 USD
|
|
2013-07-16 |
2013-07-15 |
A
Achat
|
VITULLO NICOLE
Actionnaire important
|
988 285
+inf%
6,03
5 955 801 USD
|
988 285
+inf%
|
6,03
|
5 955 801 USD
|
|
2013-07-16 |
2013-07-15 |
A
Achat
|
DOVEY BRIAN H
Actionnaire important
|
988 285
+inf%
6,03
5 955 801 USD
|
988 285
+inf%
|
6,03
|
5 955 801 USD
|
|
2012-03-14 |
2012-03-14 |
A
Achat
|
Baker Biotech Capital (GP), LLC
Actionnaire important
|
4 592
+2.0%
3,01
13 801 USD
|
4 592
+2.0%
|
3,01
|
13 801 USD
|
|
2012-03-14 |
2012-03-14 |
A
Achat
|
Baker Biotech Capital (GP), LLC
Actionnaire important
|
7 484
+3.4%
2,99
22 370 USD
|
7 484
+3.4%
|
2,99
|
22 370 USD
|
|
2012-03-14 |
2012-03-14 |
A
Achat
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
34 544
+1.0%
3,01
103 822 USD
|
34 544
+1.0%
|
3,01
|
103 822 USD
|
|
2012-03-14 |
2012-03-14 |
A
Achat
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
56 294
+1.6%
2,99
168 268 USD
|
56 294
+1.6%
|
2,99
|
168 268 USD
|
|
2012-03-14 |
2012-03-14 |
A
Achat
|
14159 capital (GP), LLC
Actionnaire important
|
910
+1.6%
3,01
2 735 USD
|
910
+1.6%
|
3,01
|
2 735 USD
|
|
2012-03-14 |
2012-03-14 |
A
Achat
|
14159 capital (GP), LLC
Actionnaire important
|
1 482
+2.7%
2,99
4 430 USD
|
1 482
+2.7%
|
2,99
|
4 430 USD
|
|
2012-03-14 |
2012-03-13 |
A
Achat
|
Baker Biotech Capital (GP), LLC
Actionnaire important
|
15 599
+7.6%
2,96
46 143 USD
|
15 599
+7.6%
|
2,96
|
46 143 USD
|
|
2012-03-14 |
2012-03-13 |
A
Achat
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
159 015
+4.8%
2,96
470 382 USD
|
159 015
+4.8%
|
2,96
|
470 382 USD
|
|
2012-03-14 |
2012-03-13 |
A
Achat
|
14159 capital (GP), LLC
Actionnaire important
|
4 186
+8.2%
2,96
12 383 USD
|
4 186
+8.2%
|
2,96
|
12 383 USD
|
|
2012-03-14 |
2012-03-12 |
A
Achat
|
Baker Biotech Capital (GP), LLC
Actionnaire important
|
56 187
+37.9%
2,55
143 277 USD
|
56 187
+37.9%
|
2,55
|
143 277 USD
|
|
2012-03-14 |
2012-03-12 |
A
Achat
|
Baker Biotech Capital (GP), LLC
Actionnaire important
|
32 155
+27.7%
2,34
75 230 USD
|
32 155
+27.7%
|
2,34
|
75 230 USD
|
|
2012-03-14 |
2012-03-12 |
A
Achat
|
Baker Biotech Capital (GP), LLC
Actionnaire important
|
4 363
+3.9%
1,87
8 159 USD
|
4 363
+3.9%
|
1,87
|
8 159 USD
|
|
2012-03-14 |
2012-03-12 |
A
Achat
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
572 737
+21.1%
2,55
1 460 479 USD
|
572 737
+21.1%
|
2,55
|
1 460 479 USD
|
|
2012-03-14 |
2012-03-12 |
A
Achat
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
327 769
+13.7%
2,34
766 848 USD
|
327 769
+13.7%
|
2,34
|
766 848 USD
|
|
2012-03-14 |
2012-03-12 |
A
Achat
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
44 467
+1.9%
1,87
83 153 USD
|
44 467
+1.9%
|
1,87
|
83 153 USD
|
|
2012-03-14 |
2012-03-12 |
A
Achat
|
14159 capital (GP), LLC
Actionnaire important
|
15 076
+41.8%
2,55
38 444 USD
|
15 076
+41.8%
|
2,55
|
38 444 USD
|
|
2012-03-14 |
2012-03-12 |
A
Achat
|
14159 capital (GP), LLC
Actionnaire important
|
8 628
+31.5%
2,34
20 186 USD
|
8 628
+31.5%
|
2,34
|
20 186 USD
|
|
2012-03-14 |
2012-03-12 |
A
Achat
|
14159 capital (GP), LLC
Actionnaire important
|
1 170
+4.5%
1,87
2 188 USD
|
1 170
+4.5%
|
1,87
|
2 188 USD
|
|
2012-03-14 |
2012-03-12 |
A
Achat
|
Baker Biotech Capital (GP), LLC
Actionnaire important
|
1 601
+1.5%
1,89
3 019 USD
|
1 601
+1.5%
|
1,89
|
3 019 USD
|
|
2012-03-14 |
2012-03-12 |
A
Achat
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
16 326
+0.7%
1,89
30 788 USD
|
16 326
+0.7%
|
1,89
|
30 788 USD
|
|
2012-03-14 |
2012-03-12 |
A
Achat
|
14159 capital (GP), LLC
Actionnaire important
|
430
+1.7%
1,89
811 USD
|
430
+1.7%
|
1,89
|
811 USD
|
|
2011-10-04 |
2011-09-30 |
A
Achat
|
Moore David
VP, Commercial Operations
Dirigeant
|
1 050
+inf%
2,58
2 709 USD
|
1 050
+inf%
|
2,58
|
2 709 USD
|
|
2011-04-06 |
2011-04-06 |
A
Achat
|
BDC CAPITAL INC.
Actionnaire important
|
1 000 000
+80.7%
4,00
4 000 000 USD
|
1 000 000
+80.7%
|
4,00
|
4 000 000 USD
|
|
2011-04-06 |
2011-04-06 |
A
Achat
|
THOMAS MCNERNEY & PARTNERS LP
Actionnaire important
|
2 966
+0.1%
4,00
11 864 USD
|
2 966
+0.1%
|
4,00
|
11 864 USD
|
|
2011-04-06 |
2011-04-06 |
A
Achat
|
THOMAS MCNERNEY & PARTNERS LP
Actionnaire important
|
14 568
+0.5%
4,00
58 272 USD
|
14 568
+0.5%
|
4,00
|
58 272 USD
|
|
2011-04-06 |
2011-04-06 |
A
Achat
|
THOMAS MCNERNEY & PARTNERS LP
Actionnaire important
|
794 966
+36.3%
4,00
3 179 864 USD
|
794 966
+36.3%
|
4,00
|
3 179 864 USD
|
|
2011-04-06 |
2011-04-06 |
A
Achat
|
H.I.G. Ventures - Tranzyme, LLC
Actionnaire important
|
812 500
+37.1%
4,00
3 250 000 USD
|
812 500
+37.1%
|
4,00
|
3 250 000 USD
|
|
2011-04-06 |
2011-04-06 |
A
Achat
|
QUAKER BIO VENTURES LP
Actionnaire important
|
375 000
+17.1%
4,00
1 500 000 USD
|
375 000
+17.1%
|
4,00
|
1 500 000 USD
|
|